NASDAQ · CHEMICALS & ALLIED PRODUCTS · MID CAP
Ascent Industries Co. ACNT
17 fiscal years on record · USD · FY2025 reported · SEC filings only
In brief
What this company does
Written from the business description in Ascent Industries Co.'s annual report to the U.S. Securities and Exchange Commission, filed 3 March 2026. Every sentence was checked against that document before publication.
Growth
USD 74.9M
Revenue, FY2025 · full 17-year series below
Revenue $M
Net income $M
FY2025 · Revenue 74.9 · Net income 0.9
Compound annual growth
−34.1%
−21.8%
−8.2%
−4.6%
−66.0%
−9.7%
−65.1%
−12.3%
+95.5%
+68.9%
+9.8%
+7.0%
3 yrs
5 yrs
10 yrs
15 yrs
Revenue compounded at −21.8% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
1 cents
of every revenue dollar became profit
Operating margin
Net margin
FY2025 · Operating -9.4% · Net 1.2%
ROE
FY2025 · ROE 1.0%
Each USD of equity produced 1 cents of profit this year.
The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.1 | 0.1 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Operating income $B | −0.0 | −0.0 | −0.0 | 0.0 | 0.0 | −0.0 | −0.0 | 0.0 | 0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBITDA $B | −0.0 | −0.0 | −0.0 | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Income tax $B | 0.0 | 0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | 0.0 | −0.0 | −0.0 | 0.0 | 0.0 | −0.0 | −0.0 | 0.0 | 0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Free cash flow $B | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 | −0.0 | 0.0 | 0.0 | −0.0 | −0.0 | −0.0 | −0.0 | 0.0 |
| EPS, diluted $ | 0.09 | −1.35 | −2.63 | 2.12 | 2.14 | −2.98 | −0.34 | · | · | · | · | · | 0.25 | 0.66 | 0.91 | 0.64 | 0.03 |
| Dividend / sh $ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.13 | 0.30 | 0.30 | 0.30 | 0.26 | 0.25 | 0.25 | 0.50 | 0.10 |
| Payout % | · | · | · | · | · | · | −0 | 17 | 86 | −0 | −23 | 48 | 128 | 38 | 27 | 78 | · |
| ROE % | 1.0 | −13.5 | −22.0 | 18.0 | 21.1 | −29.2 | −2.9 | 13.6 | 1.5 | −7.7 | −11.3 | 5.1 | 2.0 | 6.0 | 8.8 | 6.4 | 0.3 |
| Shares out B | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | · | · | · | · | · | · | · | · | · | · | · | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 67 reconciliationsAUDITED
Reconciled in 17 of 19 fiscal years. 28 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityChemicals & Allied Products
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2009